# Angio8

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/angio8

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.angio8.com
- Latest round: Series A (Sep 2, 2025)
- Investors on record: 3

## About

Based in Shenzhen, China, and established in 2021, Shenzhen TongYong Technology Co., Ltd., trading as Angio8, is a medical equipment company that provides smart robotic solutions to treat vascular diseases. In September 2025, the firm closed a round of series A+ funding from Winner Oriental Private Equity Management.

Angio8 provides vascular interventional surgery robots. It is a robotic system designed for interventional procedures targeting conditions in the heart, brain, and peripheral blood vessels. It assists surgeons in remotely controlling catheters and guide wires to perform surgical operations. The vascular interventional surgery robot equipped with artificial intelligence system, which combines virtual and physical objects to reproduce and create the environment and conditions that reflects the real surgical procedure, help doctor to simplify the procedure.

The company generates revenue from the sales of its medical robots.

## Funding rounds

- Series A, Sep 2, 2025 — Winner Oriental Private Equity Management
- Series A, May 8, 2023 — Oriental Fortune Capital, Kangyu Fund

## Investors

- Oriental Fortune Capital (https://capitalatlas.ai/funds/oriental-fortune-capital) — Series A
- Kangyu Fund — Series A
- Winner Oriental Private Equity Management (https://capitalatlas.ai/funds/winner-oriental-private-equity-management) — Series A